IN-VITRO EFFICACY OF PIPERACILLIN SULBACTAM AGAINST MULTIDRUG-RESISTANT PSEUDOMONAS AERUGINOSA: A COMPARATIVE STUDY WITH PIPERACILLIN TAZOBACTAM AND CEFOPERAZONE SULBACTAM. FMHR 2026, 4 (3), 4971-4977.